ANKRD52 — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

	Compound	Confidence	Supporting neighbours

Clinical trials — most relevant to ANKRD52 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients	PHASE2	COMPLETED
A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer	PHASE2	UNKNOWN
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma	PHASE1	COMPLETED
Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome	PHASE1	COMPLETED
Evaluating MED2005 & Nitrostat Bioavailability	PHASE1	COMPLETED
Quantification of GADD34 Expression in RA	nan	COMPLETED
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population	nan	COMPLETED
New Genes Involved in Molecular Etiology of Rett Syndrome Through DNA Microarray Comparative Genomic Hybridization	nan	COMPLETED
Autophagy in Systemic Lupus Erythematosus	nan	UNKNOWN
Family Blood Pressure Program - GenNet Network	nan	COMPLETED
IVF Outcome in Polycystic Ovary Syndrome Patients	nan	UNKNOWN
Genetics and Psychopathology in the 22q11 Deletion Syndrome	nan	UNKNOWN
Molecular Mechanisms Underlying Prostate Cancer Disparities	nan	COMPLETED
Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins.	nan	UNKNOWN
iPSC Neurons From Adult Survivors of Childhood Cancer Who Have Persistent Vincristine-Induced Neuropathy	nan	COMPLETED
Genes, Proteins, and Metabolites in Drug-resistant Epilepsy (DRE) Patients	nan	NOT_YET_RECRUITING
IP3R Modulation by Cancer Genes in Mesothelioma	nan	UNKNOWN
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants.	nan	UNKNOWN
Identification of Genes and Pathogenesis Involved in Familial Thoracic Aortic Aneurysm	nan	COMPLETED
Genetic Susceptibility to Ankylosing Spondylitis (AS) by Functional Genomics Approach	nan	COMPLETED
Relationship Between Genes Important in Blood Pressure Regulation and Blood Pressure Therapy in Hypertension	nan	COMPLETED
Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages	nan	COMPLETED
PCD New Gene Discovery	nan	COMPLETED
Validation of Gene Expression Markers of Renal Allograft Functional Decline	nan	COMPLETED
Role of Sorcin and Annexin A3 in Breast Cancer Patients	nan	UNKNOWN
Heritage Study--Genetics, Exercise and Risk Factors	nan	COMPLETED
TIPE2 Associated With Kidney Transplant	nan	SUSPENDED
Steroid Treatment of Idiopathic Nephrotic Syndrome	nan	COMPLETED
Genetic Determinants of Sudden Cardiac Death	nan	COMPLETED
Pathogenetic Basis of Aortopathy and Aortic Valve Disease	nan	ACTIVE_NOT_RECRUITING

Related proteins — ESM-2 sequence neighbours (a ANKRD52 binder may also engage these)

Protein	Name	Similarity
Q8BTI7	—	1.000	Q8BTI7 →
Q5ZLC8	—	1.000	Q5ZLC8 →
Q502K3	—	1.000	Q502K3 →
O15084	—	0.992	O15084 →
B2RXR6	—	0.991	B2RXR6 →
Q505D1	—	0.990	Q505D1 →
Q8N8A2	—	0.990	Q8N8A2 →
Q5F478	—	0.985	Q5F478 →
Q9BGT9	—	0.985	Q9BGT9 →
Q9Z2X3	—	0.984	Q9Z2X3 →
PSMD10	26S proteasome non-ATPase regulatory subunit 10	0.982	landscape →
Q0P5B9	—	0.981	Q0P5B9 →
Q9Y575	—	0.981	Q9Y575 →
A6NHY2	—	0.980	A6NHY2 →
Q14DN9	—	0.980	Q14DN9 →
Q9Y574	—	0.980	Q9Y574 →
Q91ZU0	—	0.979	Q91ZU0 →
Q9Z2X2	—	0.979	Q9Z2X2 →
Q53RE8	—	0.978	Q53RE8 →
Q9ERK0	—	0.978	Q9ERK0 →
Q9H672	—	0.978	Q9H672 →
Q9WV71	—	0.978	Q9WV71 →
Q08E43	—	0.978	Q08E43 →
Q5RCK5	—	0.977	Q5RCK5 →
Q8VHS6	—	0.977	Q8VHS6 →
Q8BLA8	—	0.977	Q8BLA8 →
Q80YE7	—	0.977	Q80YE7 →
Q4R544	—	0.976	Q4R544 →
Q6RI86	—	0.976	Q6RI86 →
Q8WXK1	—	0.976	Q8WXK1 →